Afatinib Expanded Access Program
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Registration Number
- NCT01649284
- Lead Sponsor
- Boehringer Ingelheim
- Brief Summary
This is an open-label, multi-center, single-arm trial, designed to provide early access to afatinib and to provide additional information on the safety and efficacy of afatinib in advanced NSCLC patients who harbor an EGFR mutation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- APPROVED_FOR_MARKETING
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (66)
1200.45.004 Boehringer Ingelheim Investigational Site
🇺🇸Mobile, Alabama, United States
1200.45.116 Boehringer Ingelheim Investigational Site
🇺🇸Goodyear, Arizona, United States
1200.45.078 Boehringer Ingelheim Investigational Site
🇺🇸Anaheim, California, United States
1200.45.114 Boehringer Ingelheim Investigational Site
🇺🇸Burbank, California, United States
1200.45.123 Boehringer Ingelheim Investigational Site
🇺🇸Glendale, California, United States
1200.45.117 Boehringer Ingelheim Investigational Site
🇺🇸Long Beach, California, United States
1200.45.115 Boehringer Ingelheim Investigational Site
🇺🇸Lakewood, California, United States
1200.45.102 Boehringer Ingelheim Investigational Site
🇺🇸Monterey, California, United States
1200.45.006 Boehringer Ingelheim Investigational Site
🇺🇸Ranco Cucamonga, California, United States
1200.45.098 Boehringer Ingelheim Investigational Site
🇺🇸Pleasant Hill, California, United States
1200.45.003 Boehringer Ingelheim Investigational Site
🇺🇸Southington, Connecticut, United States
1200.45.091 Boehringer Ingelheim Investigational Site
🇺🇸Pleasant Hill, California, United States
1200.45.007 Boehringer Ingelheim Investigational Site
🇺🇸Stamford, Connecticut, United States
1200.45.026 Boehringer Ingelheim Investigational Site
🇺🇸Hollywood, Florida, United States
1200.45.097 Boehringer Ingelheim Investigational Site
🇺🇸Hollywood, Florida, United States
1200.45.017 Boehringer Ingelheim Investigational Site
🇺🇸Jacksonville, Florida, United States
1200.45.016 Boehringer Ingelheim Investigational Site
🇺🇸Lakeland, Florida, United States
1200.45.103 Boehringer Ingelheim Investigational Site
🇺🇸Miami Beach, Florida, United States
1200.45.056 Boehringer Ingelheim Investigational Site
🇺🇸Port St. Lucie, Florida, United States
1200.45.119 Boehringer Ingelheim Investigational Site
🇺🇸Titusville, Florida, United States
1200.45.095 Boehringer Ingelheim Investigational Site
🇺🇸Alpharetta, Georgia, United States
1200.45.029 Boehringer Ingelheim Investigational Site
🇺🇸Athens, Georgia, United States
1200.45.042 Boehringer Ingelheim Investigational Site
🇺🇸Macon, Georgia, United States
1200.45.009 Boehringer Ingelheim Investigational Site
🇺🇸Evanston, Illinois, United States
1200.45.024 Boehringer Ingelheim Investigational Site
🇺🇸Decatur, Illinois, United States
1200.45.121 Boehringer Ingelheim Investigational Site
🇺🇸Valdosta, Georgia, United States
1200.45.087 Boehringer Ingelheim Investigational Site
🇺🇸Metairie, Louisiana, United States
1200.45.099 Boehringer Ingelheim Investigational Site
🇺🇸Peoria, Illinois, United States
1200.45.040 Boehringer Ingelheim Investigational Site
🇺🇸Waterloo, Iowa, United States
1200.45.083 Boehringer Ingelheim Investigational Site
🇺🇸Marrero, Louisiana, United States
1200.45.039 Boehringer Ingelheim Investigational Site
🇺🇸Rockville, Maryland, United States
1200.45.019 Boehringer Ingelheim Investigational Site
🇺🇸Columbia, Maryland, United States
1200.45.067 Boehringer Ingelheim Investigational Site
🇺🇸St. Louis, Missouri, United States
1200.45.100 Boehringer Ingelheim Investigational Site
🇺🇸Jackson, Mississippi, United States
1200.45.066 Boehringer Ingelheim Investigational Site
🇺🇸Freehold, New Jersey, United States
1200.45.068 Boehringer Ingelheim Investigational Site
🇺🇸Fresh Meadows, New York, United States
1200.45.105 Boehringer Ingelheim Investigational Site
🇺🇸Albuquerque, New Mexico, United States
1200.45.080 Boehringer Ingelheim Investigational Site
🇺🇸Brooklyn, New York, United States
1200.45.051 Boehringer Ingelheim Investigational Site
🇺🇸New York, New York, United States
1200.45.092 Boehringer Ingelheim Investigational Site
🇺🇸New York, New York, United States
1200.45.001 Boehringer Ingelheim Investigational Site
🇺🇸Charlotte, North Carolina, United States
1200.45.090 Boehringer Ingelheim Investigational Site
🇺🇸Canton, Ohio, United States
1200.45.005 Boehringer Ingelheim Investigational Site
🇺🇸Columbus, Ohio, United States
1200.45.089 Boehringer Ingelheim Investigational Site
🇺🇸Tulsa, Oklahoma, United States
1200.45.020 Boehringer Ingelheim Investigational Site
🇺🇸Hershey, Pennsylvania, United States
1200.45.085 Boehringer Ingelheim Investigational Site
🇺🇸Pottstown, Pennsylvania, United States
1200.45.096 Boehringer Ingelheim Investigational Site
🇺🇸Johnstown, Pennsylvania, United States
1200.45.120 Boehringer Ingelheim Investigational Site
🇺🇸Rapid City, South Dakota, United States
1200.45.060 Boehringer Ingelheim Investigational Site
🇺🇸Philadelphia, Pennsylvania, United States
1200.45.049 Boehringer Ingelheim Investigational Site
🇺🇸Cookeville, Tennessee, United States
1200.45.113 Boehringer Ingelheim Investigational Site
🇺🇸El Paso, Texas, United States
1200.45.125 Boehringer Ingelheim Investigational Site
🇺🇸Wausau, Wisconsin, United States
1200.45.093 Boehringer Ingelheim Investigational Site
🇺🇸Charleston, West Virginia, United States
1200.45.045 Boehringer Ingelheim Investigational Site
🇺🇸Fairfax, Virginia, United States
1200.45.076 Boehringer Ingelheim Investigational Site
🇺🇸Seattle, Washington, United States
1200.45.086 Boehringer Ingelheim Investigational Site
🇺🇸Bismarck, North Dakota, United States
1200.45.041 Boehringer Ingelheim Investigational Site
🇺🇸Wichita, Kansas, United States
1200.45.048 Boehringer Ingelheim Investigational Site
🇺🇸Minot, North Dakota, United States
1200.45.053 Boehringer Ingelheim Investigational Site
🇺🇸Ann Arbor, Michigan, United States
1200.45.094 Boehringer Ingelheim Investigational Site
🇺🇸Portland, Oregon, United States
1200.45.037 Boehringer Ingelheim Investigational Site
🇺🇸Orlando, Florida, United States
1200.45.046 Boehringer Ingelheim Investigational Site
🇺🇸Detroit, Michigan, United States
1200.45.021 Boehringer Ingelheim Investigational Site
🇺🇸Omaha, Nebraska, United States
1200.45.071 Boehringer Ingelheim Investigational Site
🇺🇸Billings, Montana, United States
1200.45.058 Boehringer Ingelheim Investigational Site
🇺🇸Jacksonville, Florida, United States
1200.45.057 Boehringer Ingelheim Investigational Site
🇺🇸Hot Springs, Arkansas, United States